4.7 Article

Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pharmacology & Pharmacy

Metformin: Is it Still the First Line in Type 2 Diabetes Management Algorithm?

Maria Grammatiki et al.

Summary: The prevalence of type 2 diabetes mellitus is increasing globally, significantly impacting patients' quality of life and healthcare costs. Metformin has long been considered a first-line oral therapy with beneficial effects on glycemic control and a relatively safe adverse effect profile. However, recent guidelines challenge its first-line status, making the treatment algorithms for patients with T2DM increasingly complex.

CURRENT PHARMACEUTICAL DESIGN (2021)

Review Cardiac & Cardiovascular Systems

NRF2 in Cardiovascular Diseases: a Ray of Hope!

Ruju Vashi et al.

Summary: Heart failure is a global pandemic affecting millions worldwide. Imbalanced redox homeostasis in cardiac cells leads to various cardiovascular diseases, with NRF2 potentially serving as a target for treatment. NRF2 activators may attenuate hemodynamic stress and have therapeutic effects in cardiovascular diseases.

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2021)

Review Chemistry, Medicinal

The Current and Potential Therapeutic Use of Metformin-The Good Old Drug

Jozef Drzewoski et al.

Summary: Metformin, a widely used oral antidiabetic agent, has multiple effects that may not only improve diabetes symptoms but also potentially benefit conditions such as cancer, heart disease, and kidney disease.

PHARMACEUTICALS (2021)

Article Pharmacology & Pharmacy

Novel targets of metformin in cardioprotection: beyond the effects mediated by AMPK

Samir Bolívar et al.

CURRENT PHARMACEUTICAL DESIGN (2020)

Article Biochemistry & Molecular Biology

Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health

Karianne Svendsen et al.

LIPIDS IN HEALTH AND DISEASE (2020)

Review Medicine, General & Internal

The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease

J. R. Nelson et al.

POSTGRADUATE MEDICINE (2019)

Review Pharmacology & Pharmacy

Nrf2 as a Potential Mediator of Cardiovascular Risk in Metabolic Diseases

Rafael M. da Costa et al.

FRONTIERS IN PHARMACOLOGY (2019)

Review Biochemistry & Molecular Biology

Metformin, lipids and atherosclerosis prevention

Alicia J. Jenkins et al.

CURRENT OPINION IN LIPIDOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Association between insulin resistance and the development of cardiovascular disease

Valeska Ormazabal et al.

CARDIOVASCULAR DIABETOLOGY (2018)

Editorial Material Cardiac & Cardiovascular Systems

Plasma Ceramides as Prognostic Biomarkers and Their Arterial and Myocardial Tissue Correlates in Acute Myocardial Infarction

Leonardo P. de Carvalho et al.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)

Review Cardiac & Cardiovascular Systems

Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data

L. Nesti et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)

Review Pharmacology & Pharmacy

Cytochrome P450-derived eicosanoids and heart function

K. Lockhart Jamieson et al.

PHARMACOLOGY & THERAPEUTICS (2017)

Review Endocrinology & Metabolism

Insights into Stearoyl-CoA Desaturase-1 Regulation of Systemic Metabolism

Ahmed M. ALjohani et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2017)

Review Endocrinology & Metabolism

Metformin: New Preparations and Nonglycemic Benefits

Yoshihito Fujita et al.

CURRENT DIABETES REPORTS (2017)

Review Biochemistry & Molecular Biology

Lipid metabolism and signaling in cardiac lipotoxicity

Kenneth D'Souza et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)

Review Biochemistry & Molecular Biology

Fuel availability and fate in cardiac metabolism: A tale of two substrates

Florencia Pascual et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)

Article Endocrinology & Metabolism

= METFORMIN:NONGLYCEMIC EFFECTS AND POTENTIAL NOVEL INDICATIONS

Abeer Anabtawi et al.

ENDOCRINE PRACTICE (2016)

Article Cardiac & Cardiovascular Systems

Metabolic syndrome update

Scott M. Grundy

TRENDS IN CARDIOVASCULAR MEDICINE (2016)

Review Nutrition & Dietetics

Vegetarian Diets in the Prevention and Treatment of Type 2 Diabetes

Hana Kahleova et al.

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2015)

Review Biochemistry & Molecular Biology

Metabolic reprogramming of the heart through stearoyl-CoA desaturase

Pawel Dobrzyn et al.

PROGRESS IN LIPID RESEARCH (2015)

Review Cell Biology

Metformin: From Mechanisms of Action to Therapies

Marc Foretz et al.

CELL METABOLISM (2014)

Review Pharmacology & Pharmacy

Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy

Abdulaziz M. S. Alsaad et al.

DRUG METABOLISM REVIEWS (2013)

Review Cell Biology

Lipid Metabolism and Toxicity in the Heart

Ira J. Goldberg et al.

CELL METABOLISM (2012)

Article Endocrinology & Metabolism

Lipid Composition of Cell Membranes and Its Relevance in Type 2 Diabetes Mellitus

Rob N. M. Weijers

CURRENT DIABETES REVIEWS (2012)

Review Cardiac & Cardiovascular Systems

Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation

Yangmei Deng et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)

Article Gastroenterology & Hepatology

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis

R. Loomba et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)

Article Biochemistry & Molecular Biology

DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity

Li Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Endocrinology & Metabolism

Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart

Pawel Dobrzyn et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)

Article Nutrition & Dietetics

n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases

Philip C. Calder

AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)

Article Multidisciplinary Sciences

A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy:: Modulation by dietary fat content

BN Finck et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Endocrinology & Metabolism

Serum phospholipid fatty acid composition and insulin action in type 2 diabetic patients

T Pelikánová et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2001)

Article Medicine, General & Internal

Metformin in non-alcoholic steatohepatitis

G Marchesini et al.

LANCET (2001)